Maternal Cannabis Use Disorder and Neonatal Health Outcomes: A Data Linkage Study
BJOG: An International Journal of Obstetrics & Gynaecology · 2025-03 · 132 (4) · 529-538
DOI: 10.1111/1471-0528.18024 ↗Kurz gefasst
Fachartikel in der Zeitschrift BJOG: An International Journal of Obstetrics & Gynaecology, 2025-03. Verfasst von Abay Woday Tadesse und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Population Health, Curtin University, Bentley, Australia. Hauptthemen laut MEDLINE: Marijuana Abuse, Pregnancy Complications. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 69 Literaturangaben.
Abstract (Originalsprache)
Objective
We tested for the potential associations between maternal antenatal cannabis use disorders (CUD) and neonatal health outcomes using large linked administrative data.
Design
Population‐based retrospective cohort study.
Setting
The study was conducted in New South Wales, Australia. Population or Sample A total of 215 879 singleton live births.
Methods
Generalised linear models (GLMs) fitted using log‐binomial regression to estimate risk ratios (RRs) with the corresponding 95% confidence intervals (95% CI). Additionally, we conducted a propensity score matching (PSM) analysis. Main Outcome Measures The outcomes include preterm births (PTB), low birth weight (LBW), small for gestational age (SGA), 5‐min lower Apgar scores and admission to the neonatal intensive care unit (NICU).
Results
In unmatched analyses, antenatal CUD was associated with increased risks for all adverse neonatal outcomes (adjusted risk ratio [RR] ranging from 1.47 [95% CI: 1.01, 2.14] for 5‐min lower APGAR scores to 2.58 [95% CI 2.28, 2.91] for PTB). In PSM analyses, we observed slightly attenuated risks of PTB (RR = 1.98 [1.70, 2.31]), LBW (RR = 2.46 [2.13, 2.84]), SGA (RR = 1.84 [1.44, 2.35]) and admission to NICU (RR = 1.91 [1.49, 2.45]) after matching by covariates. However, we found no significant association between antenatal CUD and 5‐min low APGAR scores (RR = 1.47 [0.94, 2.30]).
Conclusion
We found that maternal antenatal exposure to CUD is associated with a range of adverse neonatal outcomes. This study highlights that targeted interventions focusing on antenatal counselling are recommended to mitigate risks associated with maternal cannabis use.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Population Health, Curtin University, Bentley, Australia.
- Dream Science and Technology College, Dessie, Ethiopia.
- Institute for Social Sciences Research, The University of Queensland, Indooroopilly, Australia.
ORCID-Profile: Abay Woday Tadesse, Berihun Assefa Dachew
Zitieren
APA
Tadesse, A. W., Betts, K., Dachew, B. A., Ayano, G., & Alati, R. (2025). Maternal Cannabis Use Disorder and Neonatal Health Outcomes: A Data Linkage Study. BJOG: An International Journal of Obstetrics & Gynaecology. https://doi.org/10.1111/1471-0528.18024
Vancouver
Tadesse AW, Betts K, Dachew BA, Ayano G, Alati R. Maternal Cannabis Use Disorder and Neonatal Health Outcomes: A Data Linkage Study. BJOG: An International Journal of Obstetrics & Gynaecology. 2025. doi:10.1111/1471-0528.18024
BibTeX
@article{Tadesse2025,
author = {Tadesse, Abay Woday and Betts, Kim and Dachew, Berihun Assefa and Ayano, Getinet and Alati, Rosa},
title = {Maternal Cannabis Use Disorder and Neonatal Health Outcomes: A Data Linkage Study},
journal = {BJOG: An International Journal of Obstetrics & Gynaecology},
year = {2025},
doi = {10.1111/1471-0528.18024}
}
EUVIMED